Provision of a Systemic Anti-Cancer Therapy (SACT) Compounding and Nursing Service

Description

The NHS Wales Shared Services Partnership (hosted by Velindre NHS Trust) are acting on behalf of Velindre NHS Trust who sought to award a contract for a Parenteral Systemic Anti-cancer Therapy (SACT) service. This service is to be provided on behalf of Velindre Cancer Centre which is part of Velindre University NHS Trust. In recent years there has been a surge of new SACT approved by NICE / AWMSG, including immunotherapy to treat solid tumour cancers. This surge is associated with significant increased demand and associated pressure on resources, which will continue to grow as more drugs / indications are NICE approved. This requirement is to increase capacity in order to help meet SACT demand as required. The Medicines@Home Service, as part of the Pharmacy department at Velindre Cancer Centre, will operationally manage the service. Lot 1: The NHS Wales Shared Services Partnership, are acting on behalf of Velindre University NHS Trust who sought to establish a contract for a Parenteral Systemic Anti-cancer Therapy (SACT) service to be provided on behalf of Velindre Cancer Centre which is part of Velindre University NHS Trust. The purpose is to provide SACT services on behalf of Velindre Cancer Centre (a division of Velindre University NHS Trust). This includes the nursing, compounding and facility to provide a SACT service. In recent years there has been a surge of new SACT approved by NICE / AWMSG including immunotherapy to treat solid tumour cancers. This surge is associated with significant increased demand on service resource implications: i.e. medical, nursing and pharmacy staff which is expected to continue to grow as more drugs / indications are NICE approved.